Posts In: National Pharmaceutical Pricing Authority

National Pharmaceutical Pricing Authority (“NPPA”) notifies fixation of ceiling prices for Povidone Iodine; effective 21st December, 2018

January 2, 2019 OPS, Pharmaceuticals, states 0

The National Pharmaceutical Pricing Authority (“NPPA”) has revised the ceiling prices (exclusive of goods and services tax applicable, if any) of Providone Iodine by an...

Continue Reading

NPPA revises price of Metronidazole along with the dosage form, strength and unit

January 29, 2018 OPS, Pharmaceuticals, states 0

The National Pharmaceutical Pricing Authority (“NPPA”), by way of an order dated 23rd January, 2018 has fixed/revised the price of Metronidazole along with the dosage form,...

Continue Reading

NPPA introduces uniform procedure for dealing with cases of launch of new drugs without prior price approvals

November 29, 2017 Industry Specific 0

The National Pharmaceutical Pricing Authority (“NPPA”) has, vide an office memorandum dated 24th November 2017, declared that a standard and uniform procedure is to be followed in order to bring...

Continue Reading

National Pharmaceuticals Pricing Authority issues further directions in context of the Notification dated 16th August on price cap for orthopedic knee implant system

September 11, 2017 Industry Specific 0

In a recent office memorandum dated 18th August, 2017, the National Pharmaceutical Pricing Authority (“NPPA”) has issued certain directions in context of its recent gazette notification...

Continue Reading

NPPA invites representations from aggrieved companies against proposed price fixation

August 29, 2017 Industry Specific 0

In a recent Office Memorandum dated 25th August 2017, the National Pharmaceutical Pricing Authority (“NPPA”) invited all companies aggrieved by its proposed price fixation, to make representation, if...

Continue Reading

NPPA directs retailers and dealers to display the prices fixed for orthopedic knee implant system

August 29, 2017 Industry Specific 0

The National Pharmaceutical Pricing Authority (“NPPA”), vide an office memorandum dated August 25,2017, has provided a clarification with respect to the ceiling prices of orthopaedic...

Continue Reading

NPPA clarifies on the definition of ‘manufacturer’ and ‘dealer’ for implementation of ceiling price of coronary stents

August 8, 2017 Industry Specific 0

Further to the order dated 13th February, 2017 on ceiling price of Coronary Stents issued by the National Pharmaceutical Pricing Authority (“NPPA”) (reported in the trail mail), the NPPA has clarified on...

Continue Reading